Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Moelis & Company (MC) - free report >>
AC Immune (ACIU) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Moelis & Company (MC) - free report >>
AC Immune (ACIU) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 31st
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
EnerSys (ENS): This energy storage solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Enersys Price and Consensus
Enersys price-consensus-chart | Enersys Quote
Society Pass Incorporated (SOPA - Free Report) : Thisdigital platform company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
Society Pass Incorporated Price and Consensus
Society Pass Incorporated price-consensus-chart | Society Pass Incorporated Quote
Moelis & Company (MC - Free Report) : This investment banking advisory company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
Moelis & Company Price and Consensus
Moelis & Company price-consensus-chart | Moelis & Company Quote
Stitch Fix, Inc. (SFIX - Free Report) : This online fashion retailer company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.9% over the last 60 days.
Stitch Fix, Inc. Price and Consensus
Stitch Fix, Inc. price-consensus-chart | Stitch Fix, Inc. Quote
AC Immune SA (ACIU - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.5% over the last 60 days.
AC Immune Price and Consensus
AC Immune price-consensus-chart | AC Immune Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.